Sysmex (OTCMKTS:SSMXY) Trading 1.7% Higher

Sysmex Co. (OTCMKTS:SSMXYGet Free Report)’s share price was up 1.7% during mid-day trading on Monday . The stock traded as high as $20.14 and last traded at $19.28. Approximately 473,900 shares traded hands during mid-day trading, an increase of 362% from the average daily volume of 102,591 shares. The stock had previously closed at $18.95.

Sysmex Price Performance

The company has a quick ratio of 2.27, a current ratio of 3.10 and a debt-to-equity ratio of 0.10. The stock has a market cap of $12.13 billion, a P/E ratio of 37.80 and a beta of 0.84. The firm’s fifty day moving average price is $16.92 and its 200-day moving average price is $17.03.

Sysmex (OTCMKTS:SSMXYGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.11 earnings per share for the quarter. The business had revenue of $718.13 million for the quarter. Sysmex had a net margin of 10.25% and a return on equity of 11.15%. Analysts forecast that Sysmex Co. will post 0.57 earnings per share for the current year.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Featured Stories

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.